Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cheapest 12.5mg Mounjaro in the UK is not a fixed figure — private providers set their own prices, and since Eli Lilly raised its UK list price in September 2025, typical private costs for higher doses have ranged roughly £149–£375 per month depending on the dose and supplier, figures reported widely at the time. What that monthly price actually covers varies significantly between providers. Mounjaro is a prescription-only medicine, so any legitimate supply requires a clinical assessment by a prescriber; there is no legal route that skips that step. If you're comparing prices for 12.5mg specifically, the honest question is not just what the headline figure is, but what sits behind it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a reasonable thought. You're at 12.5mg, your pen is running low, and you're scanning providers the way you might scan supermarket shelves. The assumption is that Mounjaro is Mounjaro: same medicine, same pen, same result, so lowest price wins. That logic works for a box of paracetamol. It works less cleanly for a prescription-only medicine where the clinical layer around the supply is what keeps the supply safe.
What varies between providers at this dose isn't the medicine itself, it's everything that sits around it. Some headline prices for 12.5mg Mounjaro cover the pen only; the consultation, the prescription fee, and delivery are charged separately. Others bundle some of those in but charge for dose-review support or repeat prescription reviews. A few add monthly membership fees that don't appear in the advertised per-pen figure. So the cheapest listing you find may not be the cheapest once you've clicked through. Our guide to 12.5mg Mounjaro pricing walks through what to look for in that small print.
There is also a supply-chain question worth raising at the higher doses. Mounjaro must come through the licensed UK supply chain, dispensed by a pharmacy registered with the General Pharmaceutical Council and prescribable only after a clinical assessment. If you want to understand what goes into the 12.5mg Mounjaro cost before comparing providers, it helps to know what a legitimate price actually includes. If a price looks dramatically lower than the market range, it's worth asking where the medicine is actually coming from.
Eli Lilly's list-price increase in September 2025 moved the cost base for all private providers at once. The highest-dose pens saw the sharpest movement, with the 15mg list price reportedly rising from around £122 to around £330 for a four-week supply. The 12.5mg dose sits in a similar range. Private providers price from that base and add their own margin, operational costs, and whatever clinical infrastructure they maintain.
That infrastructure matters more at 12.5mg than it does at the starting dose. By the time someone reaches this strength, they've been titrating for several months. A prescriber reviewing a repeat at 12.5mg is checking more than eligibility, they're looking at how the dose increase has been tolerated, whether weight loss is continuing at a clinically meaningful rate, and whether there are any emerging reasons to pause or adjust. That review costs time and clinical expertise. Providers who price very keenly somewhere are trimming it somewhere.
The full UK price comparison for Mounjaro injections sets this out in more detail if you want to see the broader picture across doses. For a factual overview of how tirzepatide works and what it's licensed for, our Mounjaro information page is the place to start.
At nume, one price covers the clinical consultation, the prescription, the medicine, and free next-working-day delivery. There are no separate prescription charges, no delivery fees, and no recurring membership costs. Every repeat order goes through a fresh clinical review before it's approved, not a checkbox exercise, but a real prescriber looking at your case again. You can read about how our clinical team approaches that on the prescriber profile page.
The one thing our pricing doesn't include is a discount. We don't run promotional codes, seasonal offers or voucher schemes for prescription medicines. That's a deliberate choice rather than an oversight. Running price promotions on a POM would conflict with medicines advertising regulations, and more practically, it would mean varying the clinical service to subsidise a marketing incentive. Our about page sets out the reasoning behind how we've built the service.
We are not the cheapest provider of 12.5mg Mounjaro. We know that, and it doesn't bother us, because the question of who's cheapest is answering the wrong thing. The cost of a prescription medicine should reflect safe supply, proper clinical oversight, and aftercare when you need it. Those things have a floor price below which corners are being cut. Our overview of Mounjaro pricing puts all of this in context if you want a plain summary.
By 12.5mg, you are on one of the two highest doses in the licensed Mounjaro schedule. The MHRA monitors tirzepatide under its Black Triangle scheme, meaning it carries additional pharmacovigilance requirements precisely because real-world data at scale is still being gathered. The NHS tirzepatide page and the NICE appraisal TA1026 both make clear that clinical oversight throughout treatment (not just at the start) is part of what makes this medicine safe to use.
Counterfeit GLP-1 pens are a real problem in the UK. The MHRA has issued multiple warnings, and enforcement actions through 2025 included the seizure of around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million, as well as the raid of the first illicit UK site producing counterfeit tirzepatide pens. Fake pens have contained the wrong substance entirely. At 12.5mg, where you're paying more per pen than at the starter dose, our page on finding the cheapest 12.5mg Mounjaro from a legitimate source explains why the supply chain matters as much as the price. The temptation to look for a cheaper source online is understandable, but the risk of ending up with something that didn't come through the licensed UK supply chain is highest precisely in those informal markets. It's also worth knowing that the same risks apply at the starting strength, and our page on sourcing the cheapest 2.5mg Mounjaro safely covers why the same principles hold from your very first pen.
Verify any online pharmacy you're considering on the GPhC pharmacy register before ordering. A legitimately operating UK pharmacy will have a GPhC premises registration number you can look up. You can verify ours directly: our registration is 9012878. If a seller can't point you to a GPhC registration, that's a clear signal to look elsewhere. For a detailed look at what safe sourcing looks like, this page on lower-cost 12.5mg supply covers the safety side in more depth.
When you're ready to check whether you're eligible and get a clinical view on your treatment, start your free consultation, a real prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.